Lyme Disease |
Lyme Disease - Neurological Complications; Lyme Disease and other Tick-Borne Diseases; Neurological Complications Of Lyme Disease |
Clinical Trial: Effect of Intravenous Ceftriaxone and Oral Doxycycline for Lyme Neuroborreliosis. A Randomized Double-Blind Comparison.
This study is currently recruiting patients.
Verified by Sorlandet Hospital HF March 2005
|
Purpose
| Condition | Intervention | Phase |
|---|---|---|
| Neuroborreliosis | Drug: Ceftriaxone and doxycycline | Phase III |
MedlinePlus consumer health information
Study Type: Interventional
Study Design: Diagnostic, Randomized, Double-Blind, Active Control, Parallel Assignment, Efficacy Study
Study start: March 2004
Eligibility
Inclusion criteria:
Neurological symtoms and/or findings consistent with neuroborreliosis and at least one of a,b,c,d fullfiled.
- Intrathecal production of borrelia antibodies
- White cellcount in CSF > 5/mm3
- Significant rise in borrelia antibodies in two serum samples collected from a patient with at least 3 weeks interval
-
Verified acrodermatitis chronica atrophicans
-
Exclusion Criteria:
• Allergy to the contents in the medication, or earlier type I reaction to penicillin.
• Treatment with cephalosporins, penicillin or tetracyclins during the last 14 days • Pregnancy or breastfeeding • Age < 18 years
-
Location and Contact Information
Norway, Vest-Agder
Sørlandet Sykehus HF, Kristiansand, Vest-Agder, 4633, Norway; Recruiting
Unn Ljøstad, MD, Principal Investigator
Åse Mygland, MD, PhD, Study Chair, Sorlandet Sykehus HF
More Information
Last Updated: August 29, 2005
Record first received: August 29, 2005
ClinicalTrials.gov Identifier: NCT00138801
Health Authority: Norway: Directorate for Health and Social Affairs
ClinicalTrials.gov processed this record on 2005-08-30

Not Signed In -


